The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 28, 2020
Filed:
Aug. 31, 2018
Applicant:
Thomas Helledays Stiftelse För Medicinsk Forskning, Stocksund, SE;
Inventors:
Martin Scobie, Uppsala, SE;
Olov Wallner, Solna, SE;
Tobias Koolmeister, Stockholm, SE;
Karl Sven Axel Vallin, Stockholm, SE;
Carl Martin Henriksson, Bromma, SE;
Evert Homan, Sollentuna, SE;
Thomas Helleday, Stocksund, SE;
Sylvain Jacques, Lyons, FR;
Roland Julius Yu Fiskesund, Arsta, SE;
Assignee:
THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING, Stocksund, SE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/538 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/506 (2006.01); A61K 31/52 (2006.01); A61K 45/06 (2006.01); A61K 31/53 (2006.01); A61K 31/5377 (2006.01); C07D 491/048 (2006.01); C07D 487/04 (2006.01); C07D 417/12 (2006.01); C07D 413/12 (2006.01); C07D 409/12 (2006.01); C07D 409/04 (2006.01); C07D 405/12 (2006.01); C07D 405/04 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 413/14 (2006.01); C07D 239/48 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/538 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/53 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 239/48 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 409/04 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); Y02A 50/465 (2018.01);
Abstract
A compound of formula (I), or a pharmaceutically acceptable salt thereof, for use in the treatment of autoimmune diseases and inflammatory conditions.